Vysis LSI PML/RARA Dual Color, Dual Fusion Translocation Probe

For more information, contact Abbott.

Contact
Product Description
RESULTS OF HYBRIDIZATION
Product Description
Vysis LSI PML/RARA Dual Color Dual Fusion Probes hybridizes to chromosome 15q22-24 (PML SpectrumOrange) and chromosome 17q21 (Retinoic Acid Receptor α SpectrumGreen). The hybridized probe fluoresces with moderate to bright intensity both in interphase nuclei and on metaphase chromosomes.
RESULTS OF HYBRIDIZATION
In a normal cell that lacks the t(15;17), a two orange and two green signal pattern will be observed reflecting the two intact copies of RARA and PML, respectively.

This probe is provided for those interested in identifying the t(15;17). In an abnormal cell containing the t(15;17), one orange (PML), a one green (RARA), and two fusion (PML/RARA and RARA/PML) signal pattern is observed.
Normal Hybridization: Result of the hybridization of the LSI PML/RARA Dual Color, Dual Fusion Translocation Probe as observed in a normal interphase cell.
Abnormal Hybridization: Abnormal cell hybridized with the LSI PML/RARA Dual Color, Dual Fusion Translocation Probe.

The cell in this image shows the one orange (PML), one green (RARA), two fusion (PML/ RARA and RARA/PML) signal pattern indicative of the t(15;17).

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No